Literature DB >> 6891842

Purification of human tissue-type plasminogen activator in centigram quantities from human melanoma cell culture fluid and its conditioning for use in vivo.

D Collen, D C Rijken, J Van Damme, A Billiau.   

Abstract

Human tissue-type plasminogen activator was produced in centigram quantities from 50-60 1 batches of conditioned medium of a human melanoma cell culture. The yields of the procedure remained essentially unchanged during 50 subsequent preparations. The final products were of high purity as assessed by SDS gel electrophoresis. These materials, after filtration on 0.22 microM Milliporefilters were sterile and free of viruses and pyrogens. Their stability was very good in the fluid form at temperatures up to 56 degrees C. Material obtained by the present procedure has been used to investigate the biological and thrombolytic properties of tissue-type plasminogen activator.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6891842

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  12 in total

1.  Human tissue-type plasminogen activator gene located near chromosomal breakpoint in myeloproliferative disorder.

Authors:  T L Yang-Feng; G Opdenakker; G Volckaert; U Francke
Journal:  Am J Hum Genet       Date:  1986-07       Impact factor: 11.025

2.  Tissue-type plasminogen activator. Therapeutic potential in thrombotic disease states.

Authors:  D Collen
Journal:  Drugs       Date:  1986-01       Impact factor: 9.546

Review 3.  Tissue-type plasminogen activator. A review of its pharmacology and therapeutic use as a thrombolytic agent.

Authors:  D Collen; H R Lijnen; P A Todd; K L Goa
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

4.  A novel leupeptin-sensitive serine endopeptidase present in normal and malignant rat mammary tissues.

Authors:  I Eto; M D Bandy
Journal:  Mol Cell Biochem       Date:  1990-04-18       Impact factor: 3.396

5.  Methodology and results of intravenous thrombolysis in acute myocardial infarction.

Authors:  K L Neuhaus
Journal:  Cardiovasc Intervent Radiol       Date:  1986       Impact factor: 2.740

6.  Extrahepatic expression and regulation of protein C in the mouse.

Authors:  K Yamamoto; D J Loskutoff
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

7.  Coronary thrombolysis with tissue-type plasminogen activator: prospective review.

Authors:  D Collen D
Journal:  Tex Heart Inst J       Date:  1984-12

8.  Coronary thrombolysis and infarct size reduction after intravenous infusion of recombinant tissue-type plasminogen activator in nonhuman primates.

Authors:  W Flameng; F Van de Werf; J Vanhaecke; M Verstraete; D Collen
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

9.  Determination of tissue-type plasminogen-activator mRNA in human and non-human cell lines by dot-blot hybridization.

Authors:  G Opdenakker; A Billiau; G Volckaert; P de Somer
Journal:  Biochem J       Date:  1985-10-15       Impact factor: 3.857

Review 10.  Coronary thrombolysis for evolving myocardial infarction.

Authors:  J F Spann; S Sherry
Journal:  Drugs       Date:  1984-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.